The Merger and Acquisition in the Blood Products Sector after Covid-19: A Study on the Deals of China’s Enterprises
After COVID-19, the demand for blood products such as IVIG roared up immediately. Global biopharmaceutical enterprises are in a wave of M&As for expansion. While there lacks of related research on China’s blood products sector. This article takes the example of financial data from Grifols and Ch...
        Saved in:
      
    
          | Main Author: | Wang Maobang | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | EDP Sciences
    
        2024-01-01 | 
| Series: | SHS Web of Conferences | 
| Online Access: | https://www.shs-conferences.org/articles/shsconf/pdf/2024/27/shsconf_icdeba2024_01024.pdf | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    The impact of serial mergers and acquisitions on enterprises' total factor productivity: The mediating role of digital transformation.        
                          
 by: Liyan Tan, et al.
 Published: (2024-01-01)
- 
                
                    Research on Mergers and Acquisitions and Development Trends in the Pharmaceutical Industry of State-owned Enterprises        
                          
 by: Tu Lilyu
 Published: (2024-01-01)
- 
                
                    LEGAL CONSEQUENCES OF MERGERS AND ACQUISITIONS        
                          
 by: Amelia-Raluca ONIŞOR
 Published: (2016-05-01)
- 
                
                    Risk Management in Mergers and Acquisitions        
                          
 by: D. O. Verdiev
 Published: (2015-06-01)
- 
                
                    Research on the impact of enterprise mergers and acquisitions on technological innovation: An empirical analysis based on listed Chinese enterprises.        
                          
 by: Yujiao Bai, et al.
 Published: (2024-01-01)
 
       